drugset / Trial / NCT00913887

To Demonstrate the Relative Bioavailability of Diclofenac Sodium 75 mg Enteric-Coated Tablets Under Non-Fasting Conditions

NCT00913887

Phase 1 Completed 18 enrolled Sandoz
RandomizedCrossoverOpen-labelTreatment

Summary

To demonstrate the relative bioavailability of Diclofenac Sodium 75 mg enteric-coated tablets under non-fasting conditions.

Timeline

Start
1994-04
Primary completion
1994-05
Completion
1994-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 75 mg

Indications

No indication recorded.